Altimmune, Inc. (ALT) SEC Filings — 2024

Filings

• Altimmune Sells Liver Disease Business for $75M — 8-K · Dec 11, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Altimmune Q3 2024: Equity and Financial Disclosures — 10-Q · Nov 12, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Oct 16, 2024
• Altimmune Files 8-K for Security Holder Vote — 8-K · Sep 26, 2024
• Altimmune Files Definitive Proxy Statement for Annual Meeting — DEF 14A · Aug 15, 2024
• Altimmune Reports Q2 2024 Results: Revenue Up, Net Loss Widens — 10-Q · Aug 8, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
• Altimmune Appoints New CMO, Director; Reports Officer Compensation — 8-K · Jun 26, 2024
• Altimmune, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
• Altimmune, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024
• Altimmune, Inc. SC 13G Filing — SC 13G · Mar 5, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Altimmune, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Altimmune, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Janus Henderson Amends Altimmune Stake Filing — SC 13G/A · Feb 12, 2024
• BlackRock Discloses 5.0% Passive Stake in Altimmune, Inc. — SC 13G · Jan 26, 2024
• State Street Corp Updates Altimmune Stake as of Dec 31, 2023 — SC 13G/A · Jan 23, 2024